Women carrying the HBOC (Hereditary Breast and Ovarian Cancer) mutation in Japan begin the process for applying for pre-implantation genetic diagnoses (PGD). This significant move is a progressive step forward in allowing these women to ensure their offspring does not inherit their genetic disorder. As the procedure is currently not widely available in Japan, these applications mark a crucial turning point for genetic healthcare in the country.

In Japan, there is a heightened focus on genetic health, and a strong emphasis on actions that benefit the family unit as a whole. Access to such procedures as pre-implantation genetic diagnoses can reduce the genetic risk of HBOC for future generations, providing peace of mind and significant medical reassurance. As the procedure becomes more widely available, it is expected to be met with strong public support.

In the US and EU, pre-implantation genetic diagnoses are more readily available to the public and are oftentimes covered by health insurance. The process of application, though stringent, is well established. The adoption of this same procedure in Japan indicates a shift towards a more western style of genetic healthcare.